+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Treatment of advanced non small cell lung carcinoma with taxotere, Gemcitabine and G-CSF



Treatment of advanced non small cell lung carcinoma with taxotere, Gemcitabine and G-CSF



British Journal of Cancer 80(Suppl. 2): 105




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 035980868

Download citation: RISBibTeXText


Related references

Docetaxel (Taxotere) and gemcitabine in the treatment of non-small cell lung cancer: preliminary results. Seminars in Oncology 24(4 Suppl 14): S14, 1997

Cisplatin-carboplatin-gemcitabine or ifosfamide-gemcitabine in advanced non-small cell lung carcinoma: two pilot studies. Anticancer Research 19(6c): 5651-5655, 2000

A phase II randomized trial of gemcitabine-docetaxel versus gemcitabine-cisplatin in patients with advanced non-small cell lung carcinoma. Cancer ChemoTherapy and Pharmacology 64(2): 379-384, 2009

A 21-day schedule of gemcitabine and cisplatin administration in the treatment of advanced non-small cell lung carcinoma: a phase II study. Cancer Research and Treatment 36(1): 62-67, 2004

Gemcitabine plus cisplatin versus gemcitabine plus vinorelbine in treatment of advanced non-small cell lung cancer (NSCLC). Ai Zheng 23(11 Suppl): 1455-1458, 2004

Gemcitabine plus cisplatin versus gemcitabine plus vinorelbine in the treatment of advanced non-small cell lung cancer (NSCLC). Journal of Clinical Oncology 23(16_Suppl): 7329-7329, 2016

Comparison of efficacy and toxicity between gemcitabine plus carboplatin and gemcitabine plus cisplatin in the treatment of advanced non-small cell lung cancer. Zhongguo Fei Ai Za Zhi 5(6): 427-428, 2002

Nedaplatin/Gemcitabine Versus Carboplatin/Gemcitabine in Treatment of Advanced Non-small Cell Lung Cancer: A Randomized Clinical Trial. Chinese Journal of Cancer Research 24(2): 97, 2012

Phase II randomized study of vandetanib plus gemcitabine or gemcitabine plus placebo as first-line treatment of advanced non-small-cell lung cancer in elderly patients. Journal of Thoracic Oncology 9(5): 733-737, 2014

Phase III trial of gemcitabine plus carboplatin versus single-agent gemcitabine in the treatment of locally advanced or metastatic non-small-cell lung cancer: the Swedish Lung Cancer Study Group. Journal of Clinical Oncology 23(33): 8380-8388, 2005

Phase II randomized study comparing the toxicity profile of gemcitabine plus cisplatin with gemcitabine plus oral etoposide in the treatment of advanced non-small cell lung cancer. Oncology 68(4-6): 485-492, 2005

Prospective phase II trial of a combination of fixed dose rate infusion of gemcitabine with cisplatin and UFT as a first-line treatment in patients with advanced non-small-cell lung carcinoma. Lung Cancer 60(1): 83-91, 2008

Weekly gemcitabine and monthly cisplatin for advanced non-small cell lung carcinoma. Seminars in Oncology 24(3 Suppl 8): S8, 1997

Phase I study of gemcitabine and carboplatin in advanced non-small cell lung carcinoma. Lung Cancer 32(2): 189-196, 2001

Assessment and Validation of Syndromic Case Definitions for Respiratory Syncytial Virus Testing in a Low Resource Population. Pediatric Infectious Disease Journal 38(3): E57-E59, 2019